-
Here’s what fund houses bought and sold in April; do you own any?
Primarily led by liquid, equity, arbitrage, and income funds, the MF industry's AUM scaled new heights to reach Rs 32.4 lakh crore in April
-
Turnaround tales: These companies are back in black in Q4 should you invest in them
Axis Bank & Security Intelligence Services (SIS) were back in black in Q4FY21 and market experts are upbeat on the stocks
-
Should you buy RIL share post Q4 results?
Recovery in downstream cyclical margin and continued strong performance from consumer-centric business have led to most analysts being upbeat about th
-
‘Bite-sized Horlicks sachet key can be key driver for Hindustan Unilever growth’
Barring near-term uncertainties due to rising COVID-19 cases, HUL management is confident of achieving volume-led earning growth on the back of a stro
-
Axis Bank Q4: Stellar numbers can deliver up to 32% returns
Prudent provision buffer gives Axis Bank a significant cushion for any potential impact on asset quality from the second wave of the pandemic
-
HCL Tech: Buy, sell or hold after Q4 results?
Consolidated revenue from operations rose 5.7%1 to Rs 19,642 crore as against Rs 18,590 crore a year ago. On a sequential basis, topline grew at 1.8%
-
ICICI Bank Q4 earnings: Robust numbers can deliver up to 45% returns
ICICI Bank is closing in the gap with HDFC Bank on loan growth and core PPOP (pre-provision operating profit) growth
-
Forget FD, dividend-yield of these 15 stocks higher than FD rates
Dividend yield is calculated by dividing the dividend per share by the market price per share and multiplying the result by 100
-
With 6,040% returns in a decade, this pharma stock is gearing up for the next leap
Ajanta Pharma is gearing up for the next leap driven by improving operating leverage and concluding capex
-
Covid-19 cases spike: Markets likely to remain volatile in April; here’s what analysts have to say
Concerns over rising Covid-19 cases have resulted in market volatility in the the past few days
